Pregnancy outcome following first trimester exposure to antihistamines: Meta-analysis

American Journal of Perinatology

Volumn 14, Issue 3, 1997, Pages 119-124

  Seto, Arnold ^b   Einarson, Tom ^b   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

antihistamine, H1 blockers; birth defects; malformations; Pregnancy

Indexed keywords

ALIPHATIC AMINE; ANTAZOLINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZATADINE; CYPROHEPTADINE; ETHYLENEDIAMINE DERIVATIVE; LORATADINE; PHENOTHIAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; TERFENADINE; TRIPROLIDINE;

ARTICLE; BIRTH DEFECT; CLINICAL TRIAL; CONGENITAL MALFORMATION; DRUG SAFETY; FEMALE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HUMAN; HYPEREMESIS GRAVIDARUM; MAJOR CLINICAL STUDY; META ANALYSIS; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY;

EID: 0030902090     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994110     Document Type: Article

References (116)

1. Bonati M, Tognoni G. Drug use in pregnancy: A preliminary report of the International Co-operative Drug Utilization Study. Pharmaceutisch Weekblad Scientific edition 1990;12:75-8
2. Skalnick A. Key witness against morning sickness drug faces scientific fraud charges. JAMA 1990;263:1468-73
3. Einarson T, Leeder J, Koren G. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm 1988;22:813-24
4. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton MA: PSG Publishing; 1977
5. Seto A, Einarson T, Koren G. Evaluation of brompheniramine safety in pregnancy. Reprod Toxicol 1993;7: 393-5
6. Nelson M, Forfar J. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Brit Med J 1971;1:523-7
7. Ayd FJ. Haloperidol: Fifteen years of clinical experience. Dis Nerv Syst 1972;33:459-69
8. Nora J, Nora A, Sommerville R, Hill R, McNamara D. Maternal exposure to potential teratogens. JAMA 1967
9. Mellin G, Katzenstein M. Meclozine and fetal abnormalities. Brit Med J 1963;26:222-3
10. Miklovich L, Van den Berg B. An evaluation of the teratogenicity of certain antinauseant drugs. Amer J Obstet Gynecol 1976;125:244-8
11. Aselton P, Jick H. Additional followup of congenital limb disorders in relation to Bendectin use. JAMA 1983;250: 33-4
12. Eskenazi B, Bracken M. Bendectin (Debendox) as a risk factor for pyloric stenosis. Am J Obstet Gynecol 1982;144: 919-24
13. Fleming DM, Knox JDE, Crombie DL. Debendox in early pregnancy and fetal malformation. Br Med J 1981;283: 99-101
14. Michaelis J, Michaelis H, Gluck E, Koller S. Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations. Teratology 1983;27:57-64
15. Morelock S, Hingson R, Kayne H, et al. Bendectin and fetal development: A study at Boston City Hospital. Am J Obstet Gynecol 1982;142:209-13
16. Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidermiol 1979;109: 433-9
17. Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 1985;313:347-52
18. Aselton PJ, Jick H. Additional followup of congenital limb disorders in relation to Bendectin use. JAMA 1983;250: 33-4
19. Gibson GT, Colley DP, McMichael AJ, Hartshorne JM. Congenital anomalies in relation to the use of doxylamine/dicyclomine and other antenatal factors. Med J Aust 1981;1:410-14
20. Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First trimester drug use and congenital disorders. JAMA 1981; 246:343-6
21. General Practitioner Clinical Trials. Drugs in pregnancy survey. Practitioner 1963;191:775-80
22. Golding J, Vivian S, Baldwin JA. Maternal anti-nauseants and clefts of lip and palate. Hum Toxicol 1983;2:63-73
23. Greenberg G, Inman WHW, Weatherall JAC, Adalstein AM, Haskey JC. Material drug histories and congenital abnormalities. Br Med J 1977;2:853-6
24. Newman NM, Correy JF, Dudgeon GI. A survey of congenital abnormalities and drugs in a private practice. Aust NZ J Gynaecol 1977;17:156-9
25. Smithells RW, Sheppard S. Teratogenicity testing in humans: A method of demonstrating safety of Bendectin. Teratology 1978;17:31-6
26. Bunde CA, Bowles DM. A technique for controlled survey of case records. Curr Ther Res 1963;5:245-8
27. Kullander S, Kallen B. A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet Gynecol Scand 1976;55:105-11
28. Auerbach C, Barrow M. Urogenital abnormalities produced in rat fetuses with chlorcyclizine. Teratology 1972;5:23-31
29. Barrow M, Rowland C. Prolonged gestation in the rat and its usefulness in experimental teratology. Teratology 1969;2:261-74
30. Brandes J. First-trimester nausea and vomiting as related to outcome of pregnancy. Obstet Gynecol 1967;30:427-31
31. Brown N, Fabro S. The value of animal teratogenicity testing for predicting human risk. Clin Obstet Gynecol 1983; 26:467-77
32. Busse W. Chronic rhinitis. A systematic approach to diagnosis and treatment. Postgrad Med 1983;73:325-9, 333-5
33. Bierme S, Bierme R. Antihistamines in hydrops foetalis. Lancet 1967;1:574
34. Carroll J, Moir R. Use of promethazine hydrochloride in obstetrics. JAMA 1958;168:2218-24
35. Carter M, Wilson F. Ancoloxin and fetal abnormalities. B Med J 1962;2:1609
36. Charles A, Blumenthal L. Promethazine hydrochloride therapy in severely Rh-sensitized pregnancies. Obstet Gynecol 1982;60:627-30
37. Choid N, Klaponski F. On neural-tube defects: An epidemiological elicitation of etiological factors. Neurology 1970; 20:399-400
38. Corby D, Schulman I. The effects of antenatal drug administration on aggregation of platelets of newborn infants. Ped Pharmacol Ther 1971;79:307-313
39. Cordero J, Oakley GJ. Drug exposure during pregnancy: Some epidemiologic considerations. Clin Obstet Gynecol 1983;26:418-28
40. Crawford L, Cohen R. Therapy for allergic rhinitis. Comprehen Ther 1985;11:60-9
41. David A, Goodspeed A. Ancoloxin and fetal abnormalities. Brit Med J 1963;1:121
42. David M, Doyle E. First trimester pregnancy. Am J Nurs 1976;76:1945-8
43. Diggory P, Tomkinson J. Meclozine and fetal abnormalities. Lancet 1962;2:1222-3
44. Dipalma J. Drugs for nausea and vomiting of pregnancy. Am Fam Phy 1983;28:272-4
45. Donnai D, Harris R. Unusual fetal malformations after antiemetics in early pregnancy. Br Med J 1978;1:691-2
46. Failor H, Huffman M. Dystonic reactions to phenothiazine drugs. 1965;26:714-7
47. Forfar J, Nelson M. Epidemiology of drugs taken by pregnant women: Drugs that may affect the fetus adversely. Clin Pharmacol Ther 1973;14:632-41
48. Gibbs D. Diseases of the alimentary system: Nausea and vomiting. Brit Med J 1976;2:1489-92
49. Gibson J, Staples R, Larson E, Kuhn W, Holtkamp D, Newberne J. Teratology and reproduction studies with an antinauseant. Toxicol Appl Pharmacol 1968;13:439-47
50. Goldberg J, Golbus M. The value of case reports in human teratology. Am J Obstet Gynecol 1986;154:479-82
51. Greenberger P, Patterson R. Safety of therapy for allergic symptoms during pregnancy. Ann Inter Med 1978;89: 234-7
52. Guillozet N. Drug risks in pregnancy revisited. J Fam Pract 1977;4:1043-52
53. Gusdon JJ. The treatment of erythroblastosis with promethazine hydrochloride. J Reprod Med 1981;26:454-8
54. Hill R. Drugs ingested by pregnant women. Clin Pharmacol Ther 1973;14:654-9
55. Holt G, Mabry R. ENT medications in pregnancy. Otolaryng-Head and Neck Surg 1983;91:338-41
56. Huff P. Safety and drug therapy for nausea and vomiting of pregnancy. J Fam Pract 1980;11:969-70
57. Iuliucci J, Gautieri R. Morphine-induced fetal malformations. II. Influence of histamine and diphenydramine. J Pharm Sci 1971;60:420-5
58. Jaffe P, Liberman M, McFadyen I, Valman H. Incidence of congenital limb-reduction deformities. Lancet 1975;1:526-7
59. Kasperlik-Zaluska A, Migdalska B, Hartwig W, et al. Two pregnancies in a woman with Cushing's syndrome treated with cyproheptadine. Brit J Obstet Gynecol 1980;87:1171-3
60. Khir A, How J, Bewsher P. Successful pregnancy after cyproheptadine treatment for Cushing's disease. Eur J Obstet Gynecol Reprod Biol 1982;13:343-7
61. King C. Teratogenic effects of meclizine hydrochloride on the rat. Science 1963;141:353-4
62. King C, Weaver S, Derr J. Benzhydrylpiperazine antihistamines, hydramnios, and congenital malformations in the rat. Am J Obstet Gynecol 1965;93:563-5
63. King C, Howell J. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol 1966;95:109-11
64. Klingberg M, Papier C, Hart J. Birth defects monitoring. Am J Indust Med 1983;4:309-28
65. Kucera J. Congenital anomalies. Teratology 1971;4:492
66. Leathem A. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy. Clin Pharm 1986;5: 660-8
67. Lewis J, Weingold A. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol 1985;80: 912-23
68. Levin S. Problems and pitfalls in conducting epidemiological research in the area of reproductive toxicology. Am J Indust Med 1983;4:349-64
69. McBride W. Cyclizine and congenital abnormalities. Brit Med J 1963;27:1157-8
70. McColl J. Dimenhydrinate in pregnancy. Can Med Assoc J 1963;88:861
71. Milton-Thompson G. Anti-nauseant drugs. Practitioner 1979;223:516-9
72. Montminy M, Teres D. Shock after phenothiazine administration in a pregnancy patient with a pehochromocytoma. J Reprod Med 1983;28:159-61
73. Muller L, Korte A, Madle S. Mutagenicity testing of doxylamine succinate, an antinauseant drug. Toxicol Lett 1989;49:79-86
74. Niebyl J. Therapeutic drugs in pregnancy. Caution is the watchword. Postgrad Med 1984;75:165-6
75. Niebyl J. Therapeutic drugs in pregnancy. Postgrad Med 1984;75:169-72
76. Okafor B. Tracheostomy in the management of pediatric airway problems. ENTJ 1983;62:28-33
77. Patterson S. Our bundle or responsibility. Presidential address. Am J Obstet Gynecol 1984;149:245-50
78. Polednak AP. Uses of available record systems in epidemiologic studies of reproductive toxicology. Am J Indust Med 1983;4:329-48
79. Posner H, Graves A, King C, Wilk A. Experimental alteration of the metabolism of chlorcyclizine and the incidence of cleft palate in rats. 1967;155:494-505
80. Posner H, Darr A, Barrow M. Anomalies of the internal organs and diminished calcification of vertebrae in fetuses after benzhydrylpiperazine treatment of pregnant rats. Toxicol Appl Pharmacol 1970;17:76-82
81. Posner H, Darr A. Fetal edema from benzhydrylpiperazines as a possible cause of oral-facial malformations in rats. Toxicol Appl Pharmacol 1970;17:67-75
82. Ratten G. The use of drugs in pregnancy and labor. Austr Fam Phys 1978;7:1118-9
83. Riffel H, Nochimson D, Paul R, Hon E. Effects of meperidine and promethazine during labor. Obstet Gynecol 1973;42:738-45
84. Shepard T. Catalog of Teratogenic Agents. Baltimore, MD: The Johns Hopkins University Press; 1986
85. Rodriguez-Gonzalez M, Lima Perez M, Sanabria Negrin J. The effect of cyproheptadine chlorhydrate on rat embryonic development. Teratogenesis Carcinog Mutagen 1983; 3:439-46
86. Sadusk JJ, Palmisano P. Evaluation of the teratogenic effect of meclizine in man. JAMA 1965;194:987-9
87. Saxen I. Epidemiology of cleft lip and palate. An attempt to rule out chance correlations. Br J Prevent Soc Med 1975;29:103-10
88. Schardein J, Hentz D, Petrer J, Kurtz S. Teratogenesis studies with diphenhydramine HCI. Toxicol Appl Pharmacol 1971;18:971-6
89. Schenkel B, Vorherr H. Non-prescription drugs during pregnancy: Potential teratogenic and toxic effects upon embryo and fetus. J Reprod Med 1974;12:27-45
90. Schmid B, Hauser R, Donatsch P. Effects of cyproheptadine on the rat yolk sac membrane and embryonic development in vitro. Xenobiotica 1985;15:695-9
91. Shapiro S, Kaufman D, Rosenberg L, et al. Meclizine in pregnancy in relation to congenital malformations. Br Med J 1978;1:483
92. Stahlmann R, Neubert D. Which drugs are allowed, which should one avoid, which are contraindicated? Gynakologe 1987;20:129-36
93. Steffek A, King C, Derr J. The comparative pathogenesis of experimentally induced cleft palate. J Oral Ther Pharmacol 1966;3:9-16
94. Villumsen A. Congenital malformations. Teratology 1971;4:503
95. Von Almen W, Miller JJ. "T's and Blues" in pregnancy. J Reprod Med 1986;31:236-9
96. Walters W, Humphrey M. Common medical disorders in pregnancy and their treatment.
97. Walters W. The management of nausea and vomiting during pregnancy. Med J Aust 1987;147:290-1
98. Watson G. Meclozine and fetal abnormalities. Brit Med J 1962;1:1446
99. Wheatley D. Treatment of pregnancy sickness. Brit J Obstet Gynaecol 1977;84:444-7
100. Whyatt P. Astemizole in pregnancy. Austr Fam Phys 1986; 15:382-4
101. Wilk A, Steffek A, King C. Norchlorcyclizine analogs: Relationship of teratogenic activity to in vitro cartilage binding. J Pharmacol Exp Ther 1970;171:118-26
102. Wilk A, King C, Pratt RJ. Enhancement of chlorcyclizine teratogenicity in the rat by coadministration of calcium chelating agents. Teratology 1978;18:193-8
103. Wilk A, King C, Pratt R. Chlorcyclizine induction of cleft palate in the rat: Degradation of palatal glycosaminoglycans. Teratology 1978;18:199-209
104. Barcellona P. Investigations on the possible teratogenic effects of trazodone in rats and rabbits. Bollett Chim Farmac 1970;109:323-32
105. Brandstater S, Grillmaier J. Various presuppositions for epidemiologic studies on the relation between hyperemesis, use of antiemetics in pregnancy and fetal defects. Geburtshilfe Und Frauenheilkunde 1972;32:227-9
106. De Rom R. Meclizine and congenital malformations. Geburtschilfe Und Frauenheilkunde 1966;26:565-7
107. Guskova T, Golovanova V. Effect of embryogenesis of a new antiallergic agent bikarfen (Rus). Farmakologiia I Toksikologiia 1981;44:721-3
108. Karchmer S, Ontiveros E, L'opes Garcia R. Placental function and pharmacologic damage to the fetus (Spa). Maternidade e Infancia 1971;30:169-82
109. Kitschke H, Kuemmerle H. Pharmacotherapy in pregnancy. Part 4. Antidiabetics, antiemetics, neuroleptics and hormones. Munchener Medizinische Wochenschrift 1980; 122:44-5
110. Litta R, Rainone R, Zingariello L. A case of incomplete amelia. Pediatria 1983;91:287-93
111. Peszynski-Drews C. Modern views on the pathogenetic mechanisms of experimental labiopalatal clefts. Pediatria Polska 1974;49:85-92
112. Koren G. Maternal-Fetal Toxicology, 2nd ed. New York and Basel: Marcel Dekker, Inc.; 1994
113. Rosenzweig S, Blaustein FM. Cleft palate in A/J mice resulting from restraint and deprivation of food and water. Teratology 1971;3:47-51
114. Warkany J, Petering H. Congenital malformations of the brain caused by short zinc deficiencies in rats. Am J Ment Defic 1973;77:645-53
115. Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: A seroepidemiologic study. Amer J Obstet Gynecol 1987;156: 1137-41
116. Brandes JM. First trimester nausea and vomiting as related to outcome of pregnancy. Obstet Gynecol 1967;30:427-31